Comparative Effectiveness of Corticosteroid Dosages for Ultrasound-guided Glenohumeral Joint Hydrodilatation in Adhesive Capsulitis: A Randomized Controlled Trial

Jia-Chi Wang,Po-Cheng Hsu,Wei-Ting Wu,Ke-Vin Chang,Kevin A. Wang

DOI: https://doi.org/10.1016/j.apmr.2022.11.007

IF: 4.06

2022-12-14

Archives of Physical Medicine and Rehabilitation

Abstract:Objective: To investigate the efficacy of hydrodilatation with 40 mg triamcinolone acetonide (TA) compared with the same procedure with 10 mg TA in patients with adhesive capsulitis (AC) of the shoulders. Design: Prospective, double-blind, randomized controlled trial with 12 weeks of follow-up Setting: Tertiary care rehabilitation center Participants: Eighty-four patients diagnosed with AC Interventions: Ultrasound guidance using (A) hydrodilatation with 4 mL of TA (40 mg) + 4 mL 2% lidocaine hydrochloride + 12 mL normal saline or (B) hydrodilatation with 1 mL of TA (10 mg) + 4 mL 2% lidocaine hydrochloride + 15 mL normal saline through the posterior glenohumeral recess. Main Outcome Measures: Shoulder Pain and Disability Index (SPADI), visual analog scale (VAS) for pain, and range of motion (ROM) at baseline and at 6 and 12 weeks after injection. Results: Both groups experienced improvements in the SPADI score, VAS scores for pain, and ROM throughout the study period. However, group-by-time interactions were not significant for any outcome measurement at any follow-up time point. No adverse events were reported in either group. Conclusion: Ultrasound-guided hydrodilatation with 40 and 10 mg TA yielded similar improvements in SPADI, VAS score, and ROM at the 12-week follow-up. Considering the potential detrimental effects of corticosteroids on the adjacent cartilage and tendons, a low dose of TA would be preferable for ultrasound-guided hydrodilatation for AC.

rehabilitation,sport sciences